This Article Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by KRIEGER, D. T. Articles by CONDON, E. Search for Related Content PubMed PubMed Citation Articles by KRIEGER, D. T. Articles by CONDON, E.

Human Plasma Immunoreactive Lipotropin and Adrenocorticotropin in Normal Subjects and in Patients with Pituitary-Adrenal Disease^*

Department of Medicine, The Mount Sinai Medical Center, New York, New York 10029

In view of current evidence indicating that ACTH and lipotropin (LPH) are synthesized in the form of a common precursor molecule, plasma ACTH and LPH concentrations were measured simultaneously to determine if such concentrations vary concomitantly. Studies were performed in normal subjects under basal conditions and those of pituitary-adrenal stimulation (insulin-induced hypoglycemia and Pitressin administration) and suppression (dexamethasone administration). Patients with pituitary-adrenal disease (Cushing's disease, Nelson's syndrome, and Addison's disease) were studied under basal and circadian conditions and during pituitary suppression. In normal subjects, basal plasma LPH concentrations at 0800-0900 h were 6.6 ± 0.5 fmol/ml; those of ACTH were 19.4 ± 1.7 fmol/ml. Effective hypoglycemia or Pitressin administration resulted in parallel rises in plasma ACTH and LPH concentrations. Plasma ACTH and LPH concentrations at 0900 h declined significantly after midnight dexamethasone administration. Basal levels of LPH and ACTH were markedly increased in patients with Nelson's syndrome (LPH, 655 ± 34 fmol/ml; ACTH, 1028 ± 240 fmol/ml), or Addison's disease (LPH, 189 ± 16 fmol/ml; ACTH, 175 ± 7 fmol/ml), and were significantly increased in patients with Cushing's disease (LPH, 20.3 ± 7.5 fmol/ml; ACTH, 38 ± 17 fmol/ml). There was concomitant episodic ACTH and LPH secretion in patients with Nelson's syndrome. Elevated levels of LPH and ACTH in a patient with Addison's disease declined in parallel after hydrocortisone administration. A significant correlation (r = 0.9638; P > 0.001) was present between plasma ACTH and LPH concentrations in normal subjects and patients. These studies provide support for the suggestion that both hormones are simultaneously secreted. (J Clin Endocrinol Metab 48: 566, 1979)

^* This work was supported in part by USPHS Grant NB-02893-15, Grant FR-71 from the Division of Research Grants and Facilities, and the Lita Annenberg Hazen Charitable Trust.

Received August 24, 1978.

This article has been cited by other articles:

				Z.'e. Hochberg, K. Pacak, and G. P. Chrousos Endocrine Withdrawal Syndromes Endocr. Rev., August 1, 2003; 24(4): 523 - 538. [Abstract] [Full Text] [PDF]

				F. R. Ervin, R. M. Palmour, B. E. Pearson Murphy, R. Prince, and R. C. Simons The Psychobiology of Trance: II: Physiological and Endocrine Correlates Transcultural Psychiatry, January 1, 1988; 25(4): 267 - 284. [PDF]